A personal neoantigen vaccine, NEO-PV-01, with anti-PD1 induces broad de novo anti-tumor immunity in patients with metastatic melanoma, NSCLC, and bladder cancer
Ott, P.A., Govindan, R., Naing, A., Friedlander, T.W., Margolin, K., Lin, J.J., Bhardwaj, N., Hellman, M.D., Srinivasan, L., Greshock, J., Moles, M., Gaynor, R.B., Goldstein, M.J., Hu-Lieskovan, S.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article